Performance of the novel 18F-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients

被引：0
|
作者：
Dietlein, Markus [3 ]
Hohberg, Melanie [3 ]
Kobe, Carsten [3 ]
Dietlein, Felix [1 ]
Zlatopolskiy, Boris [4 ]
Krapf, Philipp [2 ]
Neumaier, Bernd [2 ]
Drzezga, Alexander [3 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Forschungszentrum Julich, Inst Neurosci & Med 5 Nucl Med, Julich, Germany
[3] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany
[4] Univ Hosp Cologne, Inst Radiochem & Expt Mol Imaging, Cologne, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
452
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prostate-specific Membrane Antigen PET in Prostate Cancer
    Lawhn-Heath, Courtney
    Salavati, Ali
    Behr, Spencer C.
    Rowe, Steven P.
    Calais, Jeremie
    Fendler, Wolfgang P.
    Eiber, Mattias
    Emmett, Louise
    Hofman, Michael S.
    Hope, Thomas A.
    RADIOLOGY, 2021, 299 (02) : 248 - 260
  • [22] 18F-labeled TTCO-PSMA Conjugate as a novel PET agent for prostate cancer imaging
    Zhang, T.
    Zhang, Z.
    Dong, G.
    Le, L.
    Ji, X.
    Peng, C.
    Li, K.
    Chen, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S755 - S755
  • [23] Prostate-specific membrane antigen (PSMA) fusion imaging in prostate cancer: PET-CT vs PET-MRI
    Liu, Feng-Yuan
    Sheng, Ting-Wen
    Tseng, Jing-Ren
    Yu, Kai-Jie
    Tsui, Ke-Hong
    Pang, Se-Tong
    Wang, Li-Jen
    Lin, Gigin
    BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1131):
  • [24] The Role of Prostate Specific Membrane Antigen (PSMA) PET/CT in the Clinical Management of Patients with Prostate Cancer
    Davidson, Tima
    Goldstein, Jeffrey
    Hahiashvili, Maia
    Goshen, Elinor
    Oksman, Yakov
    Berger, Raanan
    Saad, Akram
    Amit, Uri
    Chikman, Bar
    Symon, Zvi
    Ben-Haim, Simona
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [25] The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels
    Kabasakal, Levent
    Demirci, Emre
    Nematyazar, Jamal
    Akyel, Resit
    Razavi, Baresh
    Ocak, Meltem
    Aygun, Aslan
    Obek, Can
    Kural, Ali R.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (02) : 149 - 155
  • [26] PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) EXPRESSION AND PROSTATE CANCER SURVIVAL
    Kasperzyk, Julie
    Finn, Stephen
    Hendrickson, Whitney
    Flavin, Richard
    Fiorentino, Michelangelo
    Giovannucci, Edward
    Stampfer, Meir
    Loda, Massimo
    Mucci, Lorelei
    ANTICANCER RESEARCH, 2010, 30 (04) : 1535 - 1536
  • [27] Diagnostic performance of 18F-labeled PSMA PET/CT in patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis
    Yang, Yuan-Yuan
    Liu, Zhi-Mou
    Peng, Ru-Chen
    ACTA RADIOLOGICA, 2023, 64 (10) : 2791 - 2801
  • [28] The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients
    Guler, O. C.
    Engels, B.
    Onal, C.
    Everaert, H.
    Van den Begin, R.
    Gevaert, T.
    de Ridder, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (04): : 484 - 490
  • [29] The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients
    O. C. Guler
    B. Engels
    C. Onal
    H. Everaert
    R. Van den Begin
    T. Gevaert
    M. de Ridder
    Clinical and Translational Oncology, 2018, 20 : 484 - 490
  • [30] Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma
    Mackay, Stephen
    Oduor, Ian O.
    Burch, Tanya C.
    Troyer, Dean A.
    Semmes, Oliver J.
    Nyalwidhe, Julius O.
    PROSTATE, 2024, 84 (05): : 479 - 490
12345